메뉴 건너뛰기




Volumn 290, Issue 26, 2015, Pages 16451-16462

Synergistic binding of vascular endothelial growth factor-a and its receptors to heparin selectively modulates complex affinity

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENGINEERING; POLYSACCHARIDES; SURFACE PLASMON RESONANCE;

EID: 84941313393     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.627372     Document Type: Article
Times cited : (56)

References (53)
  • 1
    • 49149124199 scopus 로고    scopus 로고
    • Mechanisms of angiogenesis
    • Karamysheva, A. (2008) Mechanisms of angiogenesis. Biochemistry 73, 751-762
    • (2008) Biochemistry , vol.73 , pp. 751-762
    • Karamysheva, A.1
  • 2
    • 80054012347 scopus 로고    scopus 로고
    • Developmental and pathological angiogenesis
    • Chung, A. S., and Ferrara, N. (2011) Developmental and pathological angiogenesis. Annu. Rev. Cell Dev. Biol. 27, 563-584
    • (2011) Annu. Rev. Cell Dev. Biol. , vol.27 , pp. 563-584
    • Chung, A.S.1    Ferrara, N.2
  • 3
    • 0028929803 scopus 로고
    • Angiogenesis incancer, vascular, rheumatoid and other disease
    • Folkman, J. (1995) Angiogenesis incancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31
    • (1995) Nat. Med. , vol.1 , pp. 27-31
    • Folkman, J.1
  • 4
    • 33947414473 scopus 로고    scopus 로고
    • VEGF-A and the induction of pathological angiogenesis
    • Nagy, J. A., Dvorak, A. M., and Dvorak, H. F. (2007) VEGF-A and the induction of pathological angiogenesis. Annu. Rev. Pathol. 2, 251-275
    • (2007) Annu. Rev. Pathol. , vol.2 , pp. 251-275
    • Nagy, J.A.1    Dvorak, A.M.2    Dvorak, H.F.3
  • 5
    • 43249095919 scopus 로고    scopus 로고
    • Tumor angiogenesis
    • Kerbel, R. S. (2008) Tumor angiogenesis. New Engl. J. Med. 358, 2039-2049
    • (2008) New Engl. J. Med. , vol.358 , pp. 2039-2049
    • Kerbel, R.S.1
  • 6
    • 0034648765 scopus 로고    scopus 로고
    • Angiogenesis in cancer and other diseases
    • Carmeliet, P., and Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249-257
    • (2000) Nature , vol.407 , pp. 249-257
    • Carmeliet, P.1    Jain, R.K.2
  • 7
    • 30744479430 scopus 로고    scopus 로고
    • Angiogenesis in life, disease and medicine
    • Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438, 932-936
    • (2005) Nature , vol.438 , pp. 932-936
    • Carmeliet, P.1
  • 9
    • 25144511910 scopus 로고    scopus 로고
    • The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
    • Takahashi, H., and Shibuya, M. (2005) The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. 109, 227-241
    • (2005) Clin. Sci. , vol.109 , pp. 227-241
    • Takahashi, H.1    Shibuya, M.2
  • 10
    • 33646569993 scopus 로고    scopus 로고
    • Biology of vascular endothelial growth factors
    • Roy, H., Bhardwaj, S., and Ylä-Herttuala, S. (2006) Biology of vascular endothelial growth factors. FEBS Lett. 580, 2879-2887
    • (2006) FEBS Lett. , vol.580 , pp. 2879-2887
    • Roy, H.1    Bhardwaj, S.2    Ylä-Herttuala, S.3
  • 11
    • 0035062394 scopus 로고    scopus 로고
    • The splice variants of vascular endothelial growth factor (VEGF) and their receptors
    • Robinson, C. J., and Stringer, S. E. (2001) The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114, 853-865
    • (2001) J. Cell Sci. , vol.114 , pp. 853-865
    • Robinson, C.J.1    Stringer, S.E.2
  • 14
    • 0026723142 scopus 로고
    • The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules
    • Gitay-Goren, H., Soker, S., Vlodavsky, I., and Neufeld, G. (1992) The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267, 6093-6098
    • (1992) J. Biol. Chem. , vol.267 , pp. 6093-6098
    • Gitay-Goren, H.1    Soker, S.2    Vlodavsky, I.3    Neufeld, G.4
  • 15
    • 0032549799 scopus 로고    scopus 로고
    • Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
    • Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745
    • (1998) Cell , vol.92 , pp. 735-745
    • Soker, S.1    Takashima, S.2    Miao, H.Q.3    Neufeld, G.4    Klagsbrun, M.5
  • 16
    • 0034641729 scopus 로고    scopus 로고
    • Heparin sequencing brings structure to the function of complex oligosaccharides
    • Nugent, M. A. (2000) Heparin sequencing brings structure to the function of complex oligosaccharides. Proc. Natl. Acad. Sci. U. S. A. 97, 10301-10303
    • (2000) Proc. Natl. Acad. Sci. U. S. A. , vol.97 , pp. 10301-10303
    • Nugent, M.A.1
  • 17
    • 0035707396 scopus 로고    scopus 로고
    • Structure and biological interactions of heparin and heparan sulfate
    • Casu, B., and Lindahl, U. (2001) Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 57, 159-206
    • (2001) Adv. Carbohydr. Chem. Biochem. , vol.57 , pp. 159-206
    • Casu, B.1    Lindahl, U.2
  • 18
    • 84880275146 scopus 로고    scopus 로고
    • Heparan sulfate-protein binding specificity
    • Nugent, M. A., Zaia, J., and Spencer, J. L. (2013) Heparan sulfate-protein binding specificity. Biochemistry 78, 726-735
    • (2013) Biochemistry , vol.78 , pp. 726-735
    • Nugent, M.A.1    Zaia, J.2    Spencer, J.L.3
  • 19
    • 0036469507 scopus 로고    scopus 로고
    • Heparin-protein interactions
    • Capila, I., and Linhardt, R. J. (2002) Heparin-protein interactions. Angewandte Chemie 41, 391-412
    • (2002) Angewandte Chemie , vol.41 , pp. 391-412
    • Capila, I.1    Linhardt, R.J.2
  • 20
    • 0034698012 scopus 로고    scopus 로고
    • Potential mechanisms for the regulation of growth factor binding by heparin
    • Forsten, K. E., Fannon, M., and Nugent, M. A. (2000) Potential mechanisms for the regulation of growth factor binding by heparin. J. Theor. Biol. 205, 215-230
    • (2000) J. Theor. Biol. , vol.205 , pp. 215-230
    • Forsten, K.E.1    Fannon, M.2    Nugent, M.A.3
  • 21
    • 1942470528 scopus 로고    scopus 로고
    • Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly
    • Ibrahimi, O. A., Zhang, F., Hrstka, S. C., Mohammadi, M., and Linhardt, R. J. (2004) Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry 43, 4724-4730
    • (2004) Biochemistry , vol.43 , pp. 4724-4730
    • Ibrahimi, O.A.1    Zhang, F.2    Hrstka, S.C.3    Mohammadi, M.4    Linhardt, R.J.5
  • 22
    • 14644399153 scopus 로고    scopus 로고
    • The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling
    • Forsten-Williams, K., Chua, C. C., and Nugent, M. A. (2005) The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling. J. Theor. Biol. 233, 483-499
    • (2005) J. Theor. Biol. , vol.233 , pp. 483-499
    • Forsten-Williams, K.1    Chua, C.C.2    Nugent, M.A.3
  • 23
    • 0030847193 scopus 로고    scopus 로고
    • Neuropilin is a receptor for the axonal chemorepellent semaphorin III
    • He, Z., and Tessier-Lavigne, M. (1997) Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell 90, 739-751
    • (1997) Cell , vol.90 , pp. 739-751
    • He, Z.1    Tessier-Lavigne, M.2
  • 25
    • 0035816698 scopus 로고    scopus 로고
    • Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121
    • Whitaker, G. B., Limberg, B. J., and Rosenbaum, J. S. (2001) Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121. J. Biol Chem. 276, 25520-25531
    • (2001) J. Biol Chem. , vol.276 , pp. 25520-25531
    • Whitaker, G.B.1    Limberg, B.J.2    Rosenbaum, J.S.3
  • 27
    • 0036166701 scopus 로고    scopus 로고
    • Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
    • Maes, C., Carmeliet, P., Moermans, K., Stockmans, I., Smets, N., Collen, D., Bouillon, R., and Carmeliet, G. (2002) Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech. Dev. 111, 61-73
    • (2002) Mech. Dev. , vol.111 , pp. 61-73
    • Maes, C.1    Carmeliet, P.2    Moermans, K.3    Stockmans, I.4    Smets, N.5    Collen, D.6    Bouillon, R.7    Carmeliet, G.8
  • 32
    • 0024818355 scopus 로고
    • Vascular endothelial growth factor is a secreted angiogenic mitogen
    • Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309
    • (1989) Science , vol.246 , pp. 1306-1309
    • Leung, D.W.1    Cachianes, G.2    Kuang, W.J.3    Goeddel, D.V.4    Ferrara, N.5
  • 33
    • 0028990151 scopus 로고
    • VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding tothe VEGF receptorsof human melanoma cells
    • Cohen, T., Gitay-Goren, H., Sharon, R., Shibuya, M., Halaban, R., Levi, B. Z., and Neufeld, G. (1995) VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding tothe VEGF receptorsof human melanoma cells. J. Biol. Chem. 270, 11322-11326
    • (1995) J. Biol. Chem. , vol.270 , pp. 11322-11326
    • Cohen, T.1    Gitay-Goren, H.2    Sharon, R.3    Shibuya, M.4    Halaban, R.5    Levi, B.Z.6    Neufeld, G.7
  • 35
    • 0029083711 scopus 로고
    • Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent
    • Chiang, M.-K., and Flanagan, J. G. (1995) Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent. Growth Factors 12, 1-10
    • (1995) Growth Factors , vol.12 , pp. 1-10
    • Chiang, M.-K.1    Flanagan, J.G.2
  • 36
    • 0033517753 scopus 로고    scopus 로고
    • The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site
    • Park, M., and Lee, S.-T. (1999) The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site. Biochem. Biophys. Res. Commun. 264, 730-734
    • (1999) Biochem. Biophys. Res. Commun. , vol.264 , pp. 730-734
    • Park, M.1    Lee, S.-T.2
  • 37
    • 0032776557 scopus 로고    scopus 로고
    • Structural features in heparin that interact with VEGF165 and modulate its biological activity
    • Ono, K., Hattori, H., Takeshita, S., Kurita, A., and Ishihara, M. (1999) Structural features in heparin that interact with VEGF165 and modulate its biological activity. Glycobiology 9, 705-711
    • (1999) Glycobiology , vol.9 , pp. 705-711
    • Ono, K.1    Hattori, H.2    Takeshita, S.3    Kurita, A.4    Ishihara, M.5
  • 38
    • 0038482067 scopus 로고    scopus 로고
    • Regulation of vascular endothelial growth factor binding and activity by extracellular pH
    • Goerges, A. L., and Nugent, M. A. (2003) Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J. Biol. Chem. 278, 19518-19525
    • (2003) J. Biol. Chem. , vol.278 , pp. 19518-19525
    • Goerges, A.L.1    Nugent, M.A.2
  • 39
    • 84863075395 scopus 로고    scopus 로고
    • Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides
    • Zhao, W., McCallum, S. A., Xiao, Z., Zhang, F., and Linhardt, R. J. (2012) Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides. Biosci. Rep. 32, 71-81
    • (2012) Biosci. Rep. , vol.32 , pp. 71-81
    • Zhao, W.1    McCallum, S.A.2    Xiao, Z.3    Zhang, F.4    Linhardt, R.J.5
  • 40
    • 0034595635 scopus 로고    scopus 로고
    • Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells
    • Rahimi, N., Dayanir, V., and Lashkari, K. (2000) Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J. Biol. Chem. 275, 16986-16992
    • (2000) J. Biol. Chem. , vol.275 , pp. 16986-16992
    • Rahimi, N.1    Dayanir, V.2    Lashkari, K.3
  • 41
    • 16344380942 scopus 로고    scopus 로고
    • The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation
    • Singh, A. J., Meyer, R. D., Band, H., and Rahimi, N. (2005) The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation. Mol. Biol. Cell 16, 2106-2118
    • (2005) Mol. Biol. Cell , vol.16 , pp. 2106-2118
    • Singh, A.J.1    Meyer, R.D.2    Band, H.3    Rahimi, N.4
  • 42
    • 78650939979 scopus 로고    scopus 로고
    • Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability
    • Xu, D., Fuster, M. M., Lawrence, R., and Esko, J. D. (2011) Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J. Biol Chem. 286, 737-745
    • (2011) J. Biol Chem. , vol.286 , pp. 737-745
    • Xu, D.1    Fuster, M.M.2    Lawrence, R.3    Esko, J.D.4
  • 43
    • 84879807263 scopus 로고    scopus 로고
    • Determining the affinity and stoichiometry of interactions between unmodified proteins in solution using Biacore
    • Day, E. S., Capili, A. D., Borysenko, C. W., Zafari, M., and Whitty, A. (2013) Determining the affinity and stoichiometry of interactions between unmodified proteins in solution using Biacore. Anal. Biochem. 440, 96-107
    • (2013) Anal. Biochem. , vol.440 , pp. 96-107
    • Day, E.S.1    Capili, A.D.2    Borysenko, C.W.3    Zafari, M.4    Whitty, A.5
  • 44
    • 24744454378 scopus 로고    scopus 로고
    • Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells: Comparison of the effects of heparin and modified heparins
    • Ashikari-Hada, S., Habuchi, H., Kariya, Y., and Kimata, K. (2005) Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells: comparison of the effects of heparin and modified heparins. J. Biol. Chem. 280, 31508-31515
    • (2005) J. Biol. Chem. , vol.280 , pp. 31508-31515
    • Ashikari-Hada, S.1    Habuchi, H.2    Kariya, Y.3    Kimata, K.4
  • 45
    • 0035955644 scopus 로고    scopus 로고
    • Vascular Endothelial Growth Factor 165 (VEGF165) Activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF165 and VEGF165-KDR complexes
    • Hamma-Kourbali, Y., Vassy, R., Starzec, A., Le Meuth-Metzinger, V., Oudar, O., Bagheri-Yarmand, R., Perret, G., and Crepin, M. (2001) Vascular Endothelial Growth Factor 165 (VEGF165) Activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF165 and VEGF165-KDR complexes. J. Biol. Chem. 276, 39748-39754
    • (2001) J. Biol. Chem. , vol.276 , pp. 39748-39754
    • Hamma-Kourbali, Y.1    Vassy, R.2    Starzec, A.3    Le Meuth-Metzinger, V.4    Oudar, O.5    Bagheri-Yarmand, R.6    Perret, G.7    Crepin, M.8
  • 47
    • 47949089077 scopus 로고    scopus 로고
    • VEGF-targeted therapy: Mechanisms of anti-tumour activity
    • Ellis, L. M., and Hicklin, D. J. (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 8, 579-591
    • (2008) Nat. Rev. Cancer , vol.8 , pp. 579-591
    • Ellis, L.M.1    Hicklin, D.J.2
  • 48
    • 75349091269 scopus 로고    scopus 로고
    • Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling
    • Grünewald, F. S., Prota, A. E., Giese, A., and Ballmer-Hofer, K. (2010) Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling. Biochim. Biophys. Acta 1804, 567-580
    • (2010) Biochim. Biophys. Acta , vol.1804 , pp. 567-580
    • Grünewald, F.S.1    Prota, A.E.2    Giese, A.3    Ballmer-Hofer, K.4
  • 49
    • 0029021660 scopus 로고
    • Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
    • Fong, G.-H., Rossant, J., Gertsenstein, M., and Breitman, M. L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70
    • (1995) Nature , vol.376 , pp. 66-70
    • Fong, G.-H.1    Rossant, J.2    Gertsenstein, M.3    Breitman, M.L.4
  • 50
    • 66149086950 scopus 로고    scopus 로고
    • Positive and negative modulation of angiogenesis by VEGFR1 ligands
    • Cao, Y. (2009) Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci. Signal. 2, re1
    • (2009) Sci. Signal. , vol.2 , pp. re1
    • Cao, Y.1
  • 51
    • 0032482978 scopus 로고    scopus 로고
    • Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
    • Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., and Shibuya, M. (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 95, 9349-9354
    • (1998) Proc. Natl. Acad. Sci. U. S. A. , vol.95 , pp. 9349-9354
    • Hiratsuka, S.1    Minowa, O.2    Kuno, J.3    Noda, T.4    Shibuya, M.5
  • 52
    • 0037147259 scopus 로고    scopus 로고
    • Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans
    • Morimoto-Tomita, M., Uchimura, K., Werb, Z., Hemmerich, S., and Rosen, S. D. (2002) Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J. Biol. Chem. 277, 49175-49185
    • (2002) J. Biol. Chem. , vol.277 , pp. 49175-49185
    • Morimoto-Tomita, M.1    Uchimura, K.2    Werb, Z.3    Hemmerich, S.4    Rosen, S.D.5
  • 53
    • 33644657201 scopus 로고    scopus 로고
    • HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: Effects on VEGF, FGF-1, and SDF-1
    • Uchimura, K., Morimoto-Tomita, M., Bistrup, A., Li, J., Lyon, M., Gallagher, J., Werb, Z., and Rosen, S. (2006) HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem. 7, 2
    • (2006) BMC Biochem. , vol.7 , pp. 2
    • Uchimura, K.1    Morimoto-Tomita, M.2    Bistrup, A.3    Li, J.4    Lyon, M.5    Gallagher, J.6    Werb, Z.7    Rosen, S.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.